Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Takahisa Kawamura · SciRah

Researcher profile · Semantic Scholar

Takahisa Kawamura

Share profile

Takahisa Kawamura — researcher profile on SciRah

h-index: 21
Works: 85
Citations: 1,231

Most-cited papers

Rebiopsy for patients with non‐small‐cell lung cancer after epidermal growth factor receptor‐tyrosine kinase inhibitor failure
Takahisa Kawamura, H. Kenmotsu, T. Taira, S. Omori +10 more
2016Cancer Science83 citations Open access
Semantic Scholar
High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs
Takahisa Kawamura, A. Hata, Jumpei Takeshita, S. Fujita +3 more
2015Cancer Chemotherapy and Pharmacology77 citations
Semantic Scholar
Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma.
Hayato Kawachi, K. Kunimasa, Yoji Kukita, Harumi Nakamura +10 more
2021Immunotherapy62 citations Open access
Semantic Scholar
Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
T. Miyawaki, T. Naito, A. Kodama, N. Nishioka +15 more
2020JTO Clinical and Research Reports62 citations Open access
Semantic Scholar
Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.
E. Miyawaki, H. Kenmotsu, K. Mori, H. Harada +14 more
2019International Journal of Radiation Oncology, Biology, Physics57 citations
Semantic Scholar
Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis
Daichi Fujimoto, H. Ueda, Ryoko Shimizu, Ryoji Kato +11 more
2014Clinical and Experimental Metastasis55 citations
Semantic Scholar
Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR‐Mutant Non–small‐cell Lung Cancer
Takahisa Kawamura, H. Kenmotsu, S. Omori, K. Nakashima +11 more
2017Clinical Lung Cancer48 citations
Semantic Scholar
The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease
Ryoko Shimizu, Daichi Fujimoto, Ryoji Kato, T. Otoshi +9 more
2014Cancer Chemotherapy and Pharmacology48 citations
Semantic Scholar
Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation
Kosuke Tanaka, A. Hata, R. Kaji, S. Fujita +14 more
2013Journal of Thoracic Oncology46 citations Open access
Semantic Scholar
Preexisting interstitial lung disease is inversely correlated to tumor epidermal growth factor receptor mutation in patients with lung adenocarcinoma.
Daichi Fujimoto, K. Tomii, T. Otoshi, Takahisa Kawamura +15 more
2013Lung Cancer40 citations
Semantic Scholar
Association Between Clinical Tumor Burden and Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer.
T. Miyawaki, H. Kenmotsu, K. Mori, E. Miyawaki +13 more
2020Clinical Lung Cancer38 citations
Semantic Scholar
Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction.
K. Kunimasa, T. Oka, S. Hara, N. Yamada +14 more
2020Lung Cancer37 citations
Semantic Scholar
Clinical application of the AMOY 9-in-1 panel to lung cancer patients.
K. Kunimasa, S. Matsumoto, Takahisa Kawamura, Takako Inoue +7 more
2023Lung Cancer35 citations Open access
Semantic Scholar
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma
H. Kodama, K. Wakuda, M. Yabe, N. Nishioka +12 more
2020Investigational new drugs34 citations
Semantic Scholar
Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report
K. Kunimasa, J. Okami, Satoshi Takenaka, Keiichiro Honma +9 more
2021JTO Clinical and Research Reports33 citations Open access
Semantic Scholar
Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression.
K. Wakuda, M. Yabe, H. Kodama, N. Nishioka +14 more
2020Lung Cancer33 citations Open access
Semantic Scholar
Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer
H. Inoue, A. Ono, Takanori Kawabata, N. Mamesaya +13 more
2020Investigational new drugs29 citations Open access
Semantic Scholar
Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy
N. Mamesaya, K. Wakuda, K. Omae, E. Miyawaki +15 more
2018OncoTarget27 citations Open access
Semantic Scholar
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial
K. Nakashima, Y. Ozawa, H. Daga, H. Imai +9 more
2020Investigational new drugs24 citations
Semantic Scholar
Improvement strategies for successful next-generation sequencing analysis of lung cancer.
K. Kunimasa, S. Matsumoto, K. Nishino, Harumi Nakamura +12 more
2020Future Oncology22 citations Open access
Semantic Scholar
Comparison of sampling methods for next generation sequencing for patients with lung cancer
K. Kunimasa, S. Matsumoto, K. Nishino, Keiichiro Honma +10 more
2022Cancer Medicine21 citations Open access
Semantic Scholar
Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments
S. Omori, Koji Muramatsu, T. Kawata, E. Miyawaki +12 more
2021Journal of Cancer Research and Clinical Oncology20 citations Open access
Semantic Scholar
The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum
T. Fujiwara, H. Kenmotsu, T. Naito, Takahisa Kawamura +13 more
2017Cancer Chemotherapy and Pharmacology20 citations
Semantic Scholar
PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer.
E. Miyawaki, H. Murakami, K. Mori, N. Mamesaya +8 more
2020Japanese Journal of Clinical Oncology18 citations Open access
Semantic Scholar
Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolam.
Takeshi Matsumoto, K. Otsuka, Ryoji Kato, Ryoko Shimizu +8 more
2015Experimental and Therapeutic Medicine16 citations Open access
Semantic Scholar
Prognostic value of bronchoalveolar lavage in patients with non-HIV pneumocystis pneumonia.
Koji Tamai, R. Tachikawa, K. Tomii, K. Nagata +10 more
2014Internal medicine16 citations Open access
Semantic Scholar
Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice
Takuo Yamai, K. Ikezawa, N. Sugimoto, M. Urabe +16 more
2023Cancers15 citations Open access
Semantic Scholar
Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study
K. Kunimasa, N. Sugimoto, Takahisa Kawamura, Tomoyuki Yamasaki +16 more
2022Thoracic Cancer15 citations Open access
Semantic Scholar
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
Naoya Nishioka, H. Imai, M. Endo, A. Notsu +34 more
2024Targeted oncology14 citations Open access
Semantic Scholar
Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A Case Report
K. Kunimasa, Takako Inoue, Katsunori Matsueda, Takahisa Kawamura +3 more
2021JTO Clinical and Research Reports14 citations Open access
Semantic Scholar
EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors.
K. Kunimasa, Yosuke Hirotsu, Yoji Kukita, Yumi Ueda +14 more
2021Cancer Genetics12 citations
Semantic Scholar
Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer
K. Wakuda, T. Miyawaki, E. Miyawaki, N. Mamesaya +11 more
2019In Vivo12 citations Open access
Semantic Scholar
Serum procalcitonin is a valuable diagnostic marker in acute exacerbation of interstitial pneumonia
K. Nagata, K. Tomii, K. Otsuka, R. Tachikawa +8 more
2013Respirology (Carlton South. Print)12 citations
Semantic Scholar
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments
S. Omori, Koji Muramatsu, T. Kawata, E. Miyawaki +12 more
2023Investigational new drugs11 citations
Semantic Scholar
Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema
K. Kunimasa, Takahisa Kawamura, M. Tamiya, Takako Inoue +3 more
2021Thoracic Cancer11 citations Open access
Semantic Scholar
Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib.
K. Kunimasa, K. Nishino, Yoji Kukita, S. Matsumoto +10 more
2021Cancer Genetics10 citations
Semantic Scholar
Crizotinib-induced simultaneous multiple cardiac toxicities
T. Oyakawa, N. Muraoka, Kei Iida, M. Kusuhara +3 more
2018Investigational new drugs9 citations
Semantic Scholar
Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation
Takahisa Kawamura, H. Kenmotsu, Haruki Kobayashi, S. Omori +8 more
2019Investigational new drugs8 citations Open access
Semantic Scholar
Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients
H. Kenmotsu, C. Imamura, Takahisa Kawamura, T. Oyakawa +10 more
2022Cancer Chemotherapy and Pharmacology7 citations
Semantic Scholar
The impact of steroid use on efficacy of immunotherapy among patients with lung cancer who have developed immune-related adverse events.
K. Wakuda, T. Miyawaki, E. Miyawaki, N. Mamesaya +11 more
2019Journal of Clinical Oncology7 citations
Semantic Scholar
Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data
Takahisa Kawamura, H. Kasai, Valentina Fermanelli, Toshiaki Takahashi +4 more
2018Cancer Science7 citations Open access
Semantic Scholar
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
Yasunori Murata, S. Tanzawa, T. Misumi, H. Yoshioka +37 more
2023JTO Clinical and Research Reports6 citations Open access
Semantic Scholar
Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer
Taro Okayama, T. Naito, Yusuke Yonenaga, T. Ohashi +17 more
2021Supportive Care in Cancer6 citations
Semantic Scholar
Management of anorexia prevents skeletal muscle wasting during cisplatin‐based chemotherapy for thoracic malignancies
E. Miyawaki, T. Naito, K. Nakashima, T. Miyawaki +10 more
2020JCSM Clinical Reports6 citations Open access
Semantic Scholar
Acquired immunodeficiency associated with thymoma: a case report
Takahisa Kawamura, T. Naito, Haruki Kobayashi, K. Nakashima +7 more
2019BMC Cancer6 citations Open access
Semantic Scholar
Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation; a case report
K. Kunimasa, N. Sugimoto, M. Tamiya, Takako Inoue +4 more
2022Investigational new drugs5 citations Open access
Semantic Scholar
Moraxella catarrhalis bacteremic pneumonia
Hiroki Anezaki, Norohiko Terada, Takahisa Kawamura, H. Kurai
2020IDCases5 citations Open access
Semantic Scholar
Rapid Response to Sotorasib of a Patient With KRAS G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case Report
K. Kunimasa, M. Tamiya, Takako Inoue, Takahisa Kawamura +1 more
2022JTO Clinical and Research Reports4 citations Open access
Semantic Scholar
Manual route modification using an oblique method following automatic virtual bronchoscopic navigation
Takako Inoue, Takahisa Kawamura, K. Kunimasa, M. Tamiya +6 more
2022Medicine4 citations Open access
Semantic Scholar
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity
Takahisa Kawamura, C. Imamura, H. Kenmotsu, T. Taira +9 more
2020Cancer Chemotherapy and Pharmacology4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Toshiaki Takahashi×24
Invite
Toshiaki Takahashi — researcher profile on SciRah
T. Naito×22
Invite
T. Naito — researcher profile on SciRah
H. Murakami×22
Invite
H. Murakami — researcher profile on SciRah
H. Kenmotsu×21
Invite
H. Kenmotsu — researcher profile on SciRah

×21

Invite

S. Omori — researcher profile on SciRah

Invite

K. Wakuda — researcher profile on SciRah

Invite

A. Ono — researcher profile on SciRah

Haruki Kobayashi×17

Invite

Haruki Kobayashi — researcher profile on SciRah

K. Nakashima×15

Invite

K. Nakashima — researcher profile on SciRah

Invite

M. Endo — researcher profile on SciRah

K. Kunimasa×15

Invite

K. Kunimasa — researcher profile on SciRah

Invite

M. Tamiya — researcher profile on SciRah